Interpol estimates the annual turnover from pharmaceutical crime as USD 75 billion worldwide. In the US alone, the number of IPR-related seizures in the pharmaceutical and personal care industries amounts to USD 72,939,399 or 6% of the market share for FY2014. Improvements in technology, however, have allowed government officials, brand owners and experts in the field to curb this alarming trend. Within this editorial, Dr Fred Jordan of AlpVision answers the question; where are pharmaceutical anti- counterfeiting technologies headed?

Comments are closed.

%d bloggers like this: